(Q47758446)

5 February 2018

review article

1 reference

title

Induction of cell-mediated immunity during early stages of infection with intracellular protozoa (English)

1 reference

5 February 2018

0 references

R T Gazzinelli

1

1 reference

5 February 2018

A Talvani

2

1 reference

5 February 2018

M M Camargo

3

1 reference

5 February 2018

H C Santiago

4

1 reference

5 February 2018

M A Oliveira

5

1 reference

5 February 2018

L Q Vieira

6

1 reference

5 February 2018

G A Martins

7

1 reference

5 February 2018

J C Aliberti

8

1 reference

5 February 2018

J S Silva

9

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

5 February 2018

Brazilian Journal of Medical and Biological Research

published in

1 reference

5 February 2018

volume

31

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

89-104

1 reference

5 February 2018

Pathophysiology of toxoplasmosis

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Biology of Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Invasion, control and persistence of Leishmania parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Mechanism of suppression of cell-mediated immunity by measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Natural Immunity: A T-Cell-Independent Pathway of Macrophage Activation, Defined in the scid Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

The regulation of immunity to Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Recombinant interleukin 12 cures mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

T cell genetic background determines default T helper phenotype development in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

CC chemokines in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

The molecular biology of leukocyte chemoattractant receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Altered immune responses in mice lacking inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Leishmania major:Infection of Human Monocytes Induces Expression of IL-8 and MCAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

Infection with Leishmania major induces interleukin-12 production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

The third component of complement (C3) is responsible for the intracellular survival of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1998000100012

10.1590/S0100-879X1998000100012

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9686184

1 reference

5 February 2018